Results: Among 9617 identified studies, only 18 RCTs published between 1999 and 2008, including 3272 patients were finally included in this systematic evaluation. Outcome measures were categorised into quality of life (QoL),
fatigue, mood, health behaviour and social function. Six trials examined psychoeducation had inconsistent results, both during and after the primary treatment. Seven trials examined the effect of CBT, four of which given after primary treatment (range 6-12 weeks) demonstrated improvements in QoL; the other three CBT studies given during primary treatment (range 9-20 weeks) had inconsistencies. Five studies addressed social support and showed no Flavopiridol inhibitor conclusive impacts of this intervention.
Conclusions: Limited documentation exists on the efficacy of psychosocial rehabilitation GSK2126458 interventions among BC patients. However, we found that patients might have QoL benefits from CBT given after primary BC treatment. More documentation is needed regarding the effects of CBT during primary treatment and the effects of psychoeducation and social support. Copyright (C) 2010 John Wiley & Sons, Ltd.”
“Eu3+ doped Gd2O3 particles have been prepared by glycine-nitrate combustion route. Eu-O charge transfer peak shifts to higher wavelength from 260 to 273 nm with increasing
Eu3+ concentration, whereas the linewidth at half maximum intensity varies with Eu3+ concentrations and annealing temperatures as well. Lifetime for D-5(0) level of Eu3+ increases with annealing temperature from 500 to 900 degrees C, and this is related to decreasing surface
to volume atomic ratio of particles. Asymmetric ratio defined by the ratio of intensity of electrical dipole transition to that of magnetic dipole transition is found to be 10, which is more than check details the reported values (3-4) indicating enhancement in luminescence by this synthesis route.”
“Objective: The Hospital Anxiety and Depression Scale (HADS) is often used to screen for cancer caregivers’ anxiety and depression, despite few studies examining the tool’s psychometric performance within this population. The purpose of this article is to use Rasch analysis to assess the psychometric properties of the HADS in a sample of cancer caregivers.
Methods: HADS was administered to 541 caregivers of a population-based sample of patients diagnosed with one of the eight most incident cancers in Australia. Rasch analysis was conducted using RUMM2020.
Results: More than two-thirds of caregivers were women and most participants were married (95.9%) and caring for their spouse/partner with cancer (89.8%). The HADS-Anxiety (HADS-A) subscale showed good fit to the model, with appropriate internal consistency after removal of item 11. There were no disordered thresholds and no differential item functioning (DIF) for sex or age.